159 related articles for article (PubMed ID: 36807499)
1. Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Johnson SA; Phillips E; Adele S; Longet S; Malone T; Mason C; Stafford L; Jamsen A; Gardiner S; Deeks A; Neo J; Blurton EJ; White J; Ali M; Kronsteiner B; Wilson JD; Skelly DT; Jeffery K; Conlon CP; Goulder P; Consortium P; Carroll M; Barnes E; Klenerman P; Dunachie SJ
Clin Exp Immunol; 2023 Jun; 212(3):249-261. PubMed ID: 36807499
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
Mak WA; Visser W; Koeleman JGM; Ong DSY
J Virol Methods; 2024 Jun; 327():114949. PubMed ID: 38710307
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity.
Dourdouna MM; Tatsi EB; Syriopoulou V; Michos A
Diagn Microbiol Infect Dis; 2023 Jul; 106(3):115948. PubMed ID: 37094435
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers.
Phillips E; Adele S; Malone T; Deeks A; Stafford L; Dobson SL; Amini A; Skelly D; Eyre D; Jeffery K; Conlon CP; Dold C; Otter A; D'Arcangelo S; Turtle L; ; Klenerman P; Barnes E; Dunachie SJ
Clin Exp Immunol; 2022 Jul; 209(1):90-98. PubMed ID: 35522978
[TBL] [Abstract][Full Text] [Related]
5. Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination.
Fernández-González M; Agulló V; Padilla S; García JA; García-Abellán J; Botella Á; Mascarell P; Ruiz-García M; Masiá M; Gutiérrez F
Clin Infect Dis; 2022 Aug; 75(1):e338-e346. PubMed ID: 34893816
[TBL] [Abstract][Full Text] [Related]
6. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
[TBL] [Abstract][Full Text] [Related]
7. Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set.
Lamara Mahammed L; Bensaid K; Ait-Seddik S; Larinouna A; Brahimi G; Belkaid R; Hamzaoui O; Rouaki SM; Idder C; Allam I; Djidjik R
Viruses; 2023 May; 15(5):. PubMed ID: 37243265
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4
Aiello A; Coppola A; Vanini V; Petrone L; Cuzzi G; Salmi A; Altera AMG; Tortorella C; Gualano G; Gasperini C; Scolieri P; Beccacece A; Vita S; Bruzzese V; Lorenzetti R; Palmieri F; Nicastri E; Goletti D
Int J Infect Dis; 2022 Sep; 122():841-849. PubMed ID: 35878802
[TBL] [Abstract][Full Text] [Related]
9. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort.
Barreiro P; Sanz JC; San Román J; Pérez-Abeledo M; Carretero M; Megías G; Viñuela-Prieto JM; Ramos B; Canora J; Martínez-Peromingo FJ; Barba R; Zapatero A; Candel FJ
J Clin Microbiol; 2022 Mar; 60(3):e0219921. PubMed ID: 35020419
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection.
Seo YJ; Oh I; Nam M; Shin S; Roh EY; Song EY
Ann Lab Med; 2023 Nov; 43(6):596-604. PubMed ID: 37387492
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination.
Kurteva E; Vasilev G; Tumangelova-Yuzeir K; Ivanova I; Ivanova-Todorova E; Velikova T; Kyurkchiev D
Rheumatol Int; 2022 Mar; 42(3):449-456. PubMed ID: 35059799
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers.
Krüttgen A; Klingel H; Haase G; Haefner H; Imöhl M; Kleines M
J Virol Methods; 2021 Dec; 298():114295. PubMed ID: 34555429
[TBL] [Abstract][Full Text] [Related]
14. Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2.
Fonseca Brito L; Tödter S; Kottlau J; Cermann K; Spier A; Petersen E; Schäfer I; Twerenbold R; Aepfelbacher M; Lütgehetmann M; Stahl FR
Front Immunol; 2023; 14():1069968. PubMed ID: 36875076
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
[TBL] [Abstract][Full Text] [Related]
16. Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method.
Mak WA; Koeleman JGM; Ong DSY
J Virol Methods; 2022 Feb; 300():114398. PubMed ID: 34863782
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
18. Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
Sedegah M; Porter C; Goguet E; Ganeshan H; Belmonte M; Huang J; Belmonte A; Inoue S; Acheampong N; Malloy AMW; Hollis-Perry M; Jackson-Thompson B; Ramsey KF; Alcorta Y; Maiolatesi SE; Wang G; Reyes AE; Illinik L; Sanchez-Edwards M; Burgess TH; Broder CC; Laing ED; Pollett SD; Villasante E; Mitre E; Hollingdale MR
PLoS One; 2022; 17(10):e0276241. PubMed ID: 36251675
[TBL] [Abstract][Full Text] [Related]
19. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
20. Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals.
Tormo N; Navalpotro D; Martínez-Serrano M; Moreno M; Grosson F; Tur I; Guna MR; Soriano P; Tornero A; Gimeno C
Diagn Microbiol Infect Dis; 2022 Apr; 102(4):115573. PubMed ID: 35121268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
